PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating RTI Surgical Holdings, Inc. (“RTI Surgical” or the “Company”) (NASDAQ: RTIX) on behalf of the Company’s investors.
RTI Surgical investors who suffered an investment loss in excess of $100,000 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740, or via email at firstname.lastname@example.org, to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/rti-surgical/.
On March 16, 2020, RTI Surgical disclosed that its Audit Committee was “in the process of conducting an internal investigation of current and prior period matters relating to the Company’s revenue recognition practices regarding the timing of revenue with respect to certain contractual arrangements, primarily with OEM customers, including the accounting treatment, financial reporting and internal controls related to such arrangements.” Additionally, the Company disclosed that the investigation “was precipitated by an ongoing SEC investigation related to the periods 2014 through 2016.”
Following this news, shares of the Company’s stock declined $0.76 per share, or over 27% in value, to close on March 18, 2020 at $1.99 per share.
The investigation seeks to determine whether RTI Surgical and/or the Company’s executive officers and directors violated the securities laws in connection with the above, and whether investors have been harmed as a result.
RTI Surgical investors are encouraged to contact Kaskela Law LLC for additional information about this investigation. Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
This notice may constitute attorney advertising in certain jurisdictions.